Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report

With medical progress in cancer therapy, tyrosine kinase inhibitors (TKIs) became a standard of care for many cancer types. But the broad range of possible targeted therapies was accompanied by a plethora of potential resistance mechanisms, of which many have still to be identified. Here, we present...

Descripción completa

Detalles Bibliográficos
Autores principales: Ball, Markus, Christopoulos, Petros, Kirchner, Martina, Allgäuer, Michael, Brandt, Regine, Winter, Hauke, Heußel, Claus Peter, Herth, Felix, Fröhling, Stefan, Savai, Rajkumar, Kriegsmann, Mark, Schirmacher, Peter, Peters, Solange, Thomas, Michael, Stenzinger, Albrecht, Kazdal, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059782/
https://www.ncbi.nlm.nih.gov/pubmed/35058282
http://dx.doi.org/10.1101/mcs.a006156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059782/
https://www.ncbi.nlm.nih.gov/pubmed/35058282
http://dx.doi.org/10.1101/mcs.a006156

Ejemplares similares